| Open Document File Size: 360,99 KBShare Result on Facebook
Company Axtell AE / Olawaiye AB / Google / Cox / Open Access Publishing / BioMed Central Ltd. / SPSS / Lutgens LC / / Country Germany / / / Facility University Hospital Heidelberg / Tom Baker Cancer Centre / / IndustryTerm cancer therapy / treatment for endometrial cancer / online submission / / MedicalCondition distant metastases free survival / I-IV clear-cell carcinoma / early stage carcinomas / serous Introduction Uterine carcinomas / Non-endometrioid adenocarcinoma / I-II papillary serous endometrial cancer / II endometrial carcinoma / I carcinoma / I carcinomas / II carcinoma / papillary serous carcinomas / carcinoma / J Cancer / uterine papillary serous / clear cell carcinomas / endometrial cancers / uterine papillary serous cancer / local tumor / Endometrial cancer / endometrial carcinoma / I uterine papillary serous carcinoma / Local tumors / uterine papillary serous carcinoma / poorly differentiated endometrioid carcinomas / lymph node metastases / tumor / endometrioid corpus cancers / III disease / Cancer / disease / endometrioid corpus cancer / Intermediate- to High-Risk Early-Stage Endometrioid Endometrial Cancer / mixed histology carcinomas / Uterine papillary serous and clear cell carcinomas / endometrioid uterine carcinoma / papillary serous endometrial carcinomas / J Gynecol Cancer / papillary serous endometrial cancer / carcinomas / distant metastases / / MedicalTreatment radiation therapy / adjuvant chemotherapy / chemotherapy / radiotherapy / surgery / Radiation / cancer therapy / adjuvant radiotherapy / hysterectomy / brachytherapy / / OperatingSystem Microsoft Windows / / Organization Ruprecht-Karls-Universität Heidelberg / Society of Gynecologic Oncology / Department of Radiation Oncology / Tom Baker Cancer Centre / / Person Arch Gynecol Obstet / Robert Foerster / Stefan Rieken / Juergen Debus / Harald Rief / Robert Kluck / Van Nguyen-Huynh / / Position Conclusion Adjuvant RT / RT / adjuvant RT at our department / Guay MP / Adjuvant RT / Poortmans PM / / Product carboplatin / paclitaxel / taxol / / ProgrammingLanguage RC / EC / / TVStation Kapp / / Technology Radiation / chemotherapy / treating cancer / / URL www.biomedcentral.com/submit / http /
SocialTag |
Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial